查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1269398

醫療用食品市場(產品類型:錠劑，粉末，液體，其他，給藥途徑:口服，佛經腸)-全球產業分析，規模，佔有率，成長，趨勢，預測，2023年-2031年

Medical Foods Market (Product Type: Pills, Powder, Liquid, and Others; Route of Administration: Oral and Enteral) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 232 Pages | 商品交期: 2-10個工作天內

價格

醫療用食品市場- 調查範圍:

TMR 的研究報告《全球醫療用食品市場》為了提供2023年～2031年預測期間上關於市場指標的寶貴知識和見解，不僅探討了過去的增長趨勢，還調查了當前的增長趨勢和機會。本報告以 2023 年為基準年，2031 年為預測年。提供2017年到2031年的全球醫療用食品市場收益。並刊載2023年2031年的全球醫療用食品市場年複合成長率。

本報告透過廣泛研究作成。初步研究中由分析師對主要意見領袖、行業領袖和輿論製造者進行訪談，並進行大部分研究工作。二次研究則參考主要公司的產品資料、年報、新聞稿和相關文件，來掌握醫療用食品市場。

該報告深入探討全球醫療用食品市場的競爭格局。鎖定全球醫療用食品市場活動的主要企業，並對每家公司進行了不同屬性的分析。介紹企業概要，財務狀況，最近的趨勢，SWOT等全球醫療用食品市場企業的屬性。

目錄

第1章 序文

  • 市場定義和範圍
  • 市場區隔
  • 主要的調查目的
  • 調查亮點

第2章 前提條件與調查手法

第3章 摘要整理:全球市場

第4章 市場概要

  • 簡介
  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會

第5章 主要洞察

  • 新興國家市場趨勢
  • 市場進入的前3名企業
  • 有市場競爭力的新加入企業
  • 醫療用食品法規概要
  • 保險償付方案
  • 各種疾病的流通管道概要和那個外殼

第6章 全球市場分析·預測:各產品類型

  • 簡介和定義
  • 主要調查結果/開發情形
  • 市場價值預測:各產品類型，2017-2031年
    • 錠劑
    • 粉末
    • 液體
    • 其他
  • 市場魅力分析:各產品類型

第7章 全球市場分析·預測:各疾病類型

  • 簡介和定義
  • 主要調查結果/發展情形
  • 市場價值預測:各疾病類型，2017-2031年
    • 孤兒病
      • 裘馨氏肌肉萎縮症(DMD)
      • 鐮狀細胞貧血症
      • 血友病
      • 其他
    • 癌症
    • 神經·精神疾病
    • 代謝性疾病
    • 疼痛管理
    • 消化器官系統疾病
    • 眼科領域
    • 糖尿病
    • 苯酮尿症(PKU)
    • 癲癇
  • 市場魅力分析:各疾病類型

第8章 全球市場分析·預測:各給藥途徑

  • 簡介和定義
  • 主要調查結果/發展情形
  • 市場價值預測:各給藥途徑，2017年～2031年
    • 口服
    • 佛經腸
  • 市場魅力分析:各給藥途徑

第9章 全球市場分析·預測:各流通管道

  • 簡介和定義
  • 主要調查結果/發展情形
  • 市場價值預測:各流通管道，2017-2031年
    • 藥局·藥妝店
    • 線上流通管道
    • 超級市場&大賣場
    • 其他
  • 市場魅力分析:各流通管道

第10章 全球市場分析·預測:各地區

  • 主要調查結果
  • 市場規模預測:各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲地區
  • 市場魅力分析:各地區

第11章 北美市場分析·預測

  • 簡介
    • 主要調查結果
  • 市場價值預測:各產品類型，2017-2031年
    • 錠劑
    • 粉末
    • 液體
    • 其他
  • 市場價值預測:各疾病類型，2017-2031年
    • 孤兒病
      • 裘馨氏肌肉萎縮症(DMD)
      • 鐮狀細胞貧血症
      • 血友病
      • 其他
    • 癌症
    • 神經·精神疾病
    • 代謝性疾病
    • 疼痛管理
    • 消化器官系統疾病
    • 眼科領域
    • 糖尿病
    • 苯酮尿症(PKU)
    • 癲癇
  • 市場價值預測:各給藥途徑，2017-2031年
    • 口服
    • 佛經腸
  • 市場價值預測:各流通管道，2017-2031年
    • 藥局·藥妝店
    • 線上流通管道
    • 超級市場&大賣場
    • 其他
  • 市場價值預測:各國，2017-2031年
    • 美國
    • 加拿大
  • 市場魅力分析
    • 各產品
    • 各疾病類型
    • 各給藥途徑
    • 各銷售管道
    • 各國

第12章 歐洲市場分析與預測

  • 簡介
    • 主要的調查結果
  • 市場價值預測:各產品類型，2017-2031年
    • 錠劑
    • 粉末
    • 液體
    • 其他
  • 市場價值預測:各疾病類型，2017-2031年
    • 孤兒病
      • 裘馨氏肌肉萎縮症(DMD)
      • 鐮狀細胞貧血症
      • 血友病
      • 其他
    • 癌症
    • 神經·精神疾病
    • 代謝性疾病
    • 疼痛管理
    • 消化器官系統疾病
    • 眼科領域
    • 糖尿病
    • 苯酮尿症(PKU)
    • 癲癇
  • 市場價值預測:各給藥途徑，2017-2031年
    • 口服
    • 佛經腸
  • 市場價值預測:各流通管道，2017-2031年
    • 藥局·藥妝店
    • 線上流通管道
    • 超級市場&大賣場
    • 其他
  • 市場價值預測:國家·小各地區，2017-2031年
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲
  • 市場魅力分析
    • 各產品類型
    • 各疾病類型
    • 各給藥途徑
    • 各銷售管道
    • 各國/子地區

第13章 亞太地區的市場分析與預測

  • 簡介
    • 主要調查結果
  • 市場價值預測:各產品類型，2017-2031年
    • 錠劑
    • 粉末
    • 液體
    • 其他
  • 市場價值預測:各疾病類型，2017-2031年
    • 孤兒病
      • 裘馨氏肌肉萎縮症(DMD)
      • 鐮狀細胞貧血症
      • 血友病
      • 其他
    • 癌症
    • 神經·精神疾病
    • 代謝性疾病
    • 疼痛管理
    • 消化器官系統疾病
    • 眼科領域
    • 糖尿病
    • 苯酮尿症(PKU)
    • 癲癇
  • 市場價值預測:各給藥途徑，2017-2031年
    • 口服劑
    • 佛經腸
  • 市場價值預測:各流通管道，2017-2031年
    • 藥局·藥妝店
    • 線上流通管道
    • 超級市場&大賣場
    • 其他
  • 市場價值預測:國家·小各地區，2017-2031年
    • 中國
    • 日本
    • 印度
    • 澳洲·紐西蘭
    • 其他亞太地區
  • 市場魅力分析
    • 各產品類型
    • 各疾病類型
    • 各給藥途徑
    • 各銷售管道
    • 各國/子地區

第14章 南美的市場分析·預測

  • 簡介
    • 主要的調查結果
  • 市場價值預測:各產品類型，2017年～2031年
    • 錠劑
    • 粉末
    • 液體
    • 其他
  • 市場價值預測:各疾病類型，2017-2031年
    • 孤兒病
      • 裘馨氏肌肉萎縮症(DMD)
      • 鐮狀細胞貧血症
      • 血友病
      • 其他
    • 癌症
    • 神經·精神疾病
    • 代謝性疾病
    • 疼痛管理
    • 消化器官系統疾病
    • 眼科領域
    • 糖尿病
    • 苯酮尿症(PKU)
    • 癲癇
  • 市場價值預測:各給藥途徑，2017-2031年
    • 口服劑
    • 佛經腸
  • 市場價值預測:各流通管道，2017-2031年
    • 藥局·藥妝店
    • 線上流通管道
    • 超級市場&大賣場
    • 其他
  • 市場價值預測:國家·小各地區，2017-2031年
    • 巴西
    • 墨西哥
    • 其他南美國家地區
  • 市場魅力分析
    • 各產品類型
    • 各疾病類型
    • 各給藥途徑
    • 各銷售管道
    • 各國/子地區

第15章 中東·非洲市場分析與預測

  • 簡介
    • 主要調查結果
  • 市場價值預測:各產品類型，2017年～2031年
    • 錠劑
    • 粉末
    • 液體
    • 其他
  • 市場價值預測:各疾病類型，2017-2031年
    • 孤兒病
      • 裘馨氏肌肉萎縮症(DMD)
      • 鐮狀細胞貧血症
      • 血友病
      • 其他
    • 癌症
    • 神經·精神疾病
    • 代謝性疾病
    • 疼痛管理
    • 消化器官系統疾病
    • 眼科領域
    • 糖尿病
    • 苯酮尿症(PKU)
    • 癲癇
  • 市場價值預測:各給藥途徑，2017-2031年
    • 口服
    • 佛經腸
  • 市場價值預測:各流通管道，2017-2031年
    • 藥局·藥妝店
    • 線上流通管道
    • 超級市場&大賣場
    • 其他
  • 市場價值預測:國家·小各地區，2017-2031年
    • GCC各國
    • 南非
    • 其他中東·非洲
  • 市場魅力分析
    • 各產品類型
    • 各疾病類型
    • 各給藥途徑
    • 各銷售管道
    • 各國/子地區

第16章 競爭情形

  • 市場競爭-競爭矩陣(企業各層級，不同企業規模)
  • 競爭的商務策略
  • 企業簡介
    • Nutricia(Danone)
    • Nestle S.A.
    • Abbott Laboratories
    • Mead Johnson Nutrition
    • Fresenius Kabi
    • Friso
    • Morinaga Milk Industry
    • Primus Pharmaceuticals, Inc.
    • Targeted Medical Pharma, Inc.
    • Medtrition, Inc.
Product Code: TMRGL45447

Medical Foods Market - Scope of Report:

TMR's report on the global medical foods market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global medical foods market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global medical foods market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the medical foods market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global medical foods market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global medical foods market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global medical foods market.

The report delves into the competitive landscape of the global medical foods market. Key players operating in the global medical foods market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global medical foods market profiled in this report.

Key Questions Answered in Global Medical Foods Market Report:

  • What is the sales/revenue generated by medical foods across all regions during the forecast period?
  • What are the opportunities in the global medical foods market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Medical Foods Market - Research Objectives and Research Approach:

The comprehensive report on the global medical foods market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global medical foods market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global medical foods market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Medical Foods Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities

5. Key Insights

  • 5.1. Important market developments
  • 5.2. Top 3 Players Operating in the Market Space
  • 5.3. New competitive market entrants
  • 5.4. Medical food regulation overview
  • 5.5. Reimbursement Scenario
  • 5.6. Overview of the Distribution Channel of Medical Foods in various diseases along with examples

6. Global Medical Foods Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. Pills
    • 6.3.2. Powder
    • 6.3.3. Liquid
    • 6.3.4. Others
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Medical Foods Market Analysis and Forecast, by Disease Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Disease Type, 2017-2031
    • 7.3.1. Orphan Disease
      • 7.3.1.1. Duchenne Muscular Dystrophy (DMD)
      • 7.3.1.2. Sickle Cell Anemia
      • 7.3.1.3. Hemophilia
      • 7.3.1.4. Others
    • 7.3.2. Cancer
    • 7.3.3. Neurological & Psychological Disorders
    • 7.3.4. Metabolic Disorders
    • 7.3.5. Pain Management
    • 7.3.6. Gastrointestinal Disorders
    • 7.3.7. Ophthalmology
    • 7.3.8. Diabetes
    • 7.3.9. Phenylketonuria (PKU)
    • 7.3.10. Epilepsy
  • 7.4. Market Attractiveness Analysis, by Disease Type

8. Global Medical Foods Market Analysis and Forecast, by Route of Administration

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Route of Administration, 2017-2031
    • 8.3.1. Oral
    • 8.3.2. Enteral
  • 8.4. Market Attractiveness Analysis, by Route of Administration

9. Global Medical Foods Market Analysis and Forecast, by Distribution Channel

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 9.3.1. Pharmacies & Drug Stores
    • 9.3.2. Online Channels
    • 9.3.3. Supermarkets & Hypermarkets
    • 9.3.4. Others
  • 9.4. Market Attractiveness Analysis, by Distribution Channel

10. Global Medical Foods Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, by Region

11. North America Medical Foods Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2017-2031
    • 11.2.1. Pills
    • 11.2.2. Powder
    • 11.2.3. Liquid
    • 11.2.4. Others
  • 11.3. Market Value Forecast, by Disease Type, 2017-2031
    • 11.3.1. Orphan Disease
      • 11.3.1.1. Duchenne Muscular Dystrophy (DMD)
      • 11.3.1.2. Sickle Cell Anemia
      • 11.3.1.3. Hemophilia
      • 11.3.1.4. Others
    • 11.3.2. Cancer
    • 11.3.3. Neurological & Psychological Disorders
    • 11.3.4. Metabolic Disorders
    • 11.3.5. Pain Management
    • 11.3.6. Gastrointestinal Disorders
    • 11.3.7. Ophthalmology
    • 11.3.8. Diabetes
    • 11.3.9. Phenylketonuria (PKU)
    • 11.3.10. Epilepsy
  • 11.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 11.4.1. Oral
    • 11.4.2. Enteral
  • 11.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.5.1. Pharmacies & Drug Stores
    • 11.5.2. Online Channels
    • 11.5.3. Supermarkets & Hypermarkets
    • 11.5.4. Others
  • 11.6. Market Value Forecast, by Country, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product
    • 11.7.2. By Disease Type
    • 11.7.3. By Route of Administration
    • 11.7.4. By Distribution Channel
    • 11.7.5. By Country

12. Europe Medical Foods Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017-2031
    • 12.2.1. Pills
    • 12.2.2. Powder
    • 12.2.3. Liquid
    • 12.2.4. Others
  • 12.3. Market Value Forecast, by Disease Type, 2017-2031
    • 12.3.1. Orphan Disease
      • 12.3.1.1. Duchenne Muscular Dystrophy (DMD)
      • 12.3.1.2. Sickle Cell Anemia
      • 12.3.1.3. Hemophilia
      • 12.3.1.4. Others
    • 12.3.2. Cancer
    • 12.3.3. Neurological & Psychological Disorders
    • 12.3.4. Metabolic Disorders
    • 12.3.5. Pain Management
    • 12.3.6. Gastrointestinal Disorders
    • 12.3.7. Ophthalmology
    • 12.3.8. Diabetes
    • 12.3.9. Phenylketonuria (PKU)
    • 12.3.10. Epilepsy
  • 12.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 12.4.1. Oral
    • 12.4.2. Enteral
  • 12.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.5.1. Pharmacies & Drug Stores
    • 12.5.2. Online Channels
    • 12.5.3. Supermarkets & Hypermarkets
    • 12.5.4. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. by Product Type
    • 12.7.2. By Disease Type
    • 12.7.3. By Route of Administration
    • 12.7.4. By Distribution Channel
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Medical Foods Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017-2031
    • 13.2.1. Pills
    • 13.2.2. Powder
    • 13.2.3. Liquid
    • 13.2.4. Others
  • 13.3. Market Value Forecast, by Disease Type, 2017-2031
    • 13.3.1. Orphan Disease
      • 13.3.1.1. Duchenne Muscular Dystrophy (DMD)
      • 13.3.1.2. Sickle Cell Anemia
      • 13.3.1.3. Hemophilia
      • 13.3.1.4. Others
    • 13.3.2. Cancer
    • 13.3.3. Neurological & Psychological Disorders
    • 13.3.4. Metabolic Disorders
    • 13.3.5. Pain Management
    • 13.3.6. Gastrointestinal Disorders
    • 13.3.7. Ophthalmology
    • 13.3.8. Diabetes
    • 13.3.9. Phenylketonuria (PKU)
    • 13.3.10. Epilepsy
  • 13.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 13.4.1. Oral
    • 13.4.2. Enteral
  • 13.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.5.1. Pharmacies & Drug Stores
    • 13.5.2. Online Channels
    • 13.5.3. Supermarkets & Hypermarkets
    • 13.5.4. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. by Product Type
    • 13.7.2. By Disease Type
    • 13.7.3. By Route of Administration
    • 13.7.4. By Distribution Channel
    • 13.7.5. By Country/Sub-region

14. Latin America Medical Foods Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2017-2031
    • 14.2.1. Pills
    • 14.2.2. Powder
    • 14.2.3. Liquid
    • 14.2.4. Others
  • 14.3. Market Value Forecast, by Disease Type, 2017-2031
    • 14.3.1. Orphan Disease
      • 14.3.1.1. Duchenne Muscular Dystrophy (DMD)
      • 14.3.1.2. Sickle Cell Anemia
      • 14.3.1.3. Hemophilia
      • 14.3.1.4. Others
    • 14.3.2. Cancer
    • 14.3.3. Neurological & Psychological Disorders
    • 14.3.4. Metabolic Disorders
    • 14.3.5. Pain Management
    • 14.3.6. Gastrointestinal Disorders
    • 14.3.7. Ophthalmology
    • 14.3.8. Diabetes
    • 14.3.9. Phenylketonuria (PKU)
    • 14.3.10. Epilepsy
  • 14.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 14.4.1. Oral
    • 14.4.2. Enteral
  • 14.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.5.1. Pharmacies & Drug Stores
    • 14.5.2. Online Channels
    • 14.5.3. Supermarkets & Hypermarkets
    • 14.5.4. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. by Product Type
    • 14.7.2. By Disease Type
    • 14.7.3. By Route of Administration
    • 14.7.4. By Distribution Channel
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Medical Foods Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product Type, 2017-2031
    • 15.2.1. Pills
    • 15.2.2. Powder
    • 15.2.3. Liquid
    • 15.2.4. Others
  • 15.3. Market Value Forecast, by Disease Type, 2017-2031
    • 15.3.1. Orphan Disease
      • 15.3.1.1. Duchenne Muscular Dystrophy (DMD)
      • 15.3.1.2. Sickle Cell Anemia
      • 15.3.1.3. Hemophilia
      • 15.3.1.4. Others
    • 15.3.2. Cancer
    • 15.3.3. Neurological & Psychological Disorders
    • 15.3.4. Metabolic Disorders
    • 15.3.5. Pain Management
    • 15.3.6. Gastrointestinal Disorders
    • 15.3.7. Ophthalmology
    • 15.3.8. Diabetes
    • 15.3.9. Phenylketonuria (PKU)
    • 15.3.10. Epilepsy
  • 15.4. Market Value Forecast, by Route of Administration, 2017-2031
    • 15.4.1. Oral
    • 15.4.2. Enteral
  • 15.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 15.5.1. Pharmacies & Drug Stores
    • 15.5.2. Online Channels
    • 15.5.3. Supermarkets & Hypermarkets
    • 15.5.4. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. by Product Type
    • 15.7.2. By Disease Type
    • 15.7.3. By Route of Administration
    • 15.7.4. By Distribution Channel
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (by tier and size of companies)
  • 16.2. Competitive Business Strategies
  • 16.3. Company Profiles
    • 16.3.1. Nutricia (Danone)
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Nestle S.A.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Abbott Laboratories
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Mead Johnson Nutrition
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Fresenius Kabi
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Friso
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Morinaga Milk Industry
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Primus Pharmaceuticals, Inc.
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Targeted Medical Pharma, Inc.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Medtrition, Inc.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 03: Global Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017-2031
  • Table 04: Global Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 05: Global Medical Foods Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 06: Global Medical Foods Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: Europe Medical Foods Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 08: Europe Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 09: Europe Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 10: Europe Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017-2031
  • Table 11: Europe Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 12: Europe Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 13: North America Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 14: North America Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 15: North America Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017-2031
  • Table 16: North America Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 17: North America Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 18: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 19: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 20: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017-2031
  • Table 21: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 22: Asia Pacific Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 23: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 24: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 25: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017-2031
  • Table 26: Latin America Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 27: Latin America Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 28: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 29: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
  • Table 30: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Orphan Disease, 2017-2031
  • Table 31: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
  • Table 32: Middle East and Africa Medical Foods Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Global Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 02: Global Medical Foods Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 03: Global Medical Foods Market Revenue (US$ Mn), by Pills, 2017-2031
  • Figure 04: Global Medical Foods Market Revenue (US$ Mn), by Powder, 2017-2031
  • Figure 05: Global Medical Foods Market Revenue (US$ Mn), by Liquid, 2017-2031
  • Figure 06: Global Medical Foods Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 07: Global Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 08: Global Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 09: Global Medical Foods Market Revenue (US$ Mn), by Orphan Disease, 2017-2031
  • Figure 10: Global Medical Foods Market Revenue (US$ Mn), by Cancer, 2017-2031
  • Figure 11: Global Medical Foods Market Revenue (US$ Mn), by Neurological & Psychological Disorders, 2017-2031
  • Figure 12: Global Medical Foods Market Revenue (US$ Mn), by Metabolic Disorders, 2017-2031
  • Figure 13: Global Medical Foods Market Revenue (US$ Mn), by Pain Management, 2017-2031
  • Figure 14: Global Medical Foods Market Revenue (US$ Mn), by Gastrointestinal Disorders, 2017-2031
  • Figure 15: Global Medical Foods Market Revenue (US$ Mn), by Ophthalmology, 2017-2031
  • Figure 16 Global Medical Foods Market Revenue (US$ Mn), by Diabetes, 2017-2031
  • Figure 17: Global Medical Foods Market Revenue (US$ Mn), by Phenylketonuria (PKU), 2017-2031
  • Figure 18: Global Medical Foods Market Revenue (US$ Mn), by Epilepsy, 2017-2031
  • Figure 19: Global Medical Foods Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 20: Global Medical Foods Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 21: Global Medical Foods Market Revenue (US$ Mn), by Oral, 2017-2031
  • Figure 22: Global Medical Foods Market Revenue (US$ Mn), by Enteral, 2017-2031
  • Figure 23: Global Medical Foods Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 24: Global Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 25: Global Medical Foods Market Revenue (US$ Mn), by Pharmacies & Drug Stores, 2017-2031
  • Figure 26: Global Medical Foods Market Revenue (US$ Mn), by Online Channels, 2017-2031
  • Figure 27: Global Medical Foods Market Revenue (US$ Mn), by Supermarkets & Hypermarkets, 2017-2031
  • Figure 28: Global Medical Foods Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 29: Global Medical Foods Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 30: Global Medical Foods Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 31: North America Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 32: North America Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 33: North America Medical Foods Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 34: North America Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 35 North America Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 36: North America Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031
  • Figure 37: North America Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 38: North America Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 39: North America Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 40: Europe Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 41: Europe Medical Foods Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 42: Europe Medical Foods Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 43: Europe Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 44: Europe Medical Foods Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 45: Europe Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 46: Europe Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 47: Europe Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031
  • Figure 48: Europe Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 49: Europe Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 50: Europe Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 51: Asia Pacific Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 52: Asia Pacific Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 53: Asia Pacific Medical Foods Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 54: Asia Pacific Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 55: Asia Pacific Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 56: Asia Pacific Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031
  • Figure 57: Asia Pacific Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 58: Asia Pacific Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 59: Asia Pacific Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 60: Latin America Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 61: Latin America Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 62: Latin America Medical Foods Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 63: Latin America Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 64: Latin America Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 65: Latin America Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031
  • Figure 66: Latin America Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 67: Latin America Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 68: Latin America Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 69: Middle East and Africa Medical Foods Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 70: Middle East and Africa Medical Foods Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 71: Middle East and Africa Medical Foods Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 72: Middle East and Africa Medical Foods Market Value Share Analysis, by Disease Type, 2022 and 2031
  • Figure 73: Middle East and Africa Medical Foods Market Attractiveness Analysis, by Disease Type, 2023-2031
  • Figure 74: Middle East and Africa Medical Foods Market Value Share Analysis, by Route of Administration, 2021 and 2031
  • Figure 75: Middle East and Africa Medical Foods Market Attractiveness Analysis, by Route of Administration, 2022-2031
  • Figure 76: Middle East and Africa Medical Foods Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 77: Middle East and Africa Medical Foods Market Attractiveness Analysis, by Distribution Channel, 2022-2031